Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
NCT04115566 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2026-04-29
Summary
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
Conditions
Sponsors & Collaborators
-
UCB Pharma
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Haley B Naik, MD, MHSc, FAAD · University of California, San Francisco
Eligibility
- Min Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2035-05-01
- Completion
- 2035-05-01
Countries
- United States
Study Locations
More Related Trials
-
Impact of Staphylococcus Aureus on Folliculitis Decalvans
NCT02157688 ·Status: COMPLETED
-
Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa
NCT07278011 ·Status: COMPLETED
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Defects of Keratinocytes Function in Dermatologic Patients
NCT06324552 ·Status: RECRUITING
-
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
NCT00709631 ·Status: COMPLETED
-
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495 ·Status: RECRUITING
-
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma
NCT04319120 ·Status: RECRUITING
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Cutaneous Neurofibromas in People With NF1
NCT05581511 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT03272958 ·Status: COMPLETED
-
Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
NCT02798055 ·Status: COMPLETED
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
NCT05855460 ·Status: UNKNOWN
-
Scleroderma Registry & Repository at the Hospital for Special Surgery
NCT01656447 ·Status: RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
NCT05532865 ·Status: RECRUITING
-
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
NCT04901325 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
The Gut and Skin Microbiome in Vitiligo Disease Progression
NCT03577327 ·Status: RECRUITING
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
Sirolimus in Cutaneous Sarcoidosis
NCT05458492 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides
NCT05526638 ·Status: UNKNOWN ·Phase: NA
-
Evaluate the Evolution of Body and Scalp Skin Discomfort in Patients With Hereditary Ichthyosis After Wraps (EnvelopIchtyose)
NCT05979506 ·Status: RECRUITING ·Phase: NA
-
Characterization of the Cytokine Profile and the Microbiome in Darier's Disease
NCT06614777 ·Status: RECRUITING ·Phase: NA